We are live on
!
Find out more
EC
Eleva Capital Portfolio holdings
AUM
$113M
This Fund
S&P 500
This Quarter
Est. Return
-14.07%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$343M
AUM Growth
–
Cap. Flow
+$382M
Cap. Flow
% of AUM
111.1%
Top 10 Holdings %
Top 10 Hldgs %
97.63%
Holding
24
New
24
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.5
quarters
Top 10 Avg Time Held
0.6
quarters
Top 20 Avg Time Held
0.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$312M |
| 2 |
Amer Sports
AS
|
+$10.9M |
| 3 |
NVIDIA
NVDA
|
+$9.54M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$8.79M |
| 5 |
Netflix
NFLX
|
+$7.68M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 81.31% |
| 2 | Technology | 6.21% |
| 3 | Communication Services | 6.04% |
| 4 | Consumer Discretionary | 4.34% |
| 5 | Healthcare | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
CRH
CRH
$55.6B
| $279M | 81.27% |
+2,654,974
| New | +$312M |
2025 Q2
3 quarters
|
|
|
2
Amer Sports
AS
$16.2B
| $9.84M | 2.86% |
+298,802
| New | +$10.9M |
2025 Q2
3 quarters
|
|
|
3
NVIDIA
NVDA
$5.78T
| $9.07M | 2.64% |
+52,002
| New | +$9.54M |
2026 Q1
0 quarters
|
|
|
4
Netflix
NFLX
$286B
| $8.38M | 2.44% |
+87,190
| New | +$7.68M |
2025 Q2
3 quarters
|
|
|
5
Alphabet (Google) Class A
GOOGL
$4.25T
| $8.04M | 2.34% |
+27,967
| New | +$8.79M |
2026 Q1
0 quarters
|
|
6
TSMC
TSM
$2.5T
| $6.51M | 1.89% |
+21,411
| New | +$7.37M |
2026 Q1
0 quarters
|
|
7
Arista Networks
ANET
$272B
| $5.77M | 1.68% |
+46,957
| New | +$6.28M |
2025 Q3
2 quarters
|
|
8
Amazon
AMZN
$2.76T
| $3.36M | 0.98% |
+16,155
| New | +$3.56M |
2026 Q1
0 quarters
|
|
9
T-Mobile US
TMUS
$178B
| $3.01M | 0.88% |
+14,347
| New | +$2.95M |
2026 Q1
0 quarters
|
|
10
Robinhood
HOOD
$101B
| $2.19M | 0.64% |
+31,625
| New | +$2.78M |
2026 Q1
0 quarters
|
|
11
On Holding
ONON
$11.1B
| $1.71M | 0.5% |
+50,150
| New | +$2.19M |
2026 Q1
0 quarters
|
|
12
Boston Scientific
BSX
$61.1B
| $1.67M | 0.49% |
+26,667
| New | +$2.13M |
2026 Q1
0 quarters
|
|
13
Spotify
SPOT
$100B
| $1.32M | 0.38% |
+2,715
| New | +$1.36M |
2026 Q1
0 quarters
|
|
14
NewAmsterdam Pharma
NAMS
$2.66B
| $823K | 0.24% |
+25,721
| New | +$838K |
2026 Q1
0 quarters
|
|
15
CG Oncology
CGON
$5.64B
| $561K | 0.16% |
+8,289
| New | +$470K |
2026 Q1
0 quarters
|
|
|
ESPR
16
DELISTED
Esperion Therapeutics
ESPR
| $502K | 0.15% |
+183,047
| New | +$579K |
2026 Q1
0 quarters
|
|
17
Mineralys Therapeutics
MLYS
$1.94B
| $463K | 0.13% |
+17,081
| New | +$501K |
2026 Q1
0 quarters
|
|
18
Fennec Pharmaceuticals
FENC
$363M
| $327K | 0.1% |
+53,234
| New | +$411K |
2026 Q1
0 quarters
|
|
19
Disc Medicine
IRON
$2.37B
| $327K | 0.1% |
+5,115
| New | +$355K |
2026 Q1
0 quarters
|
|
20
Viridian Therapeutics
VRDN
$2.06B
| $139K | 0.04% |
+7,126
| New | +$212K |
2026 Q1
0 quarters
|
|
21
Freeport-McMoran
FCX
$104B
| $133K | 0.04% |
+2,258
| New | +$136K |
2026 Q1
0 quarters
|
|
22
Archer Aviation
ACHR
$3.58B
| $111K | 0.03% |
+21,534
| New | +$154K |
2026 Q1
0 quarters
|
|
23
Edgewise Therapeutics
EWTX
$4.35B
| $55K | 0.02% |
+17,460
| New | +$503K |
2026 Q1
0 quarters
|
|
24
Aquestive Therapeutics
AQST
$579M
| $11.3K | ﹤0.01% |
+2,720
| New | +$11K |
2026 Q1
0 quarters
|
|
Similar funds
ABG
IA
MBC
LAM
CPA
IIM
RSEWM
OCM
Eleva Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Eleva Capital held 24 positions worth $343M. Its ten largest holdings account for 98% of the portfolio.
Eleva Capital deployed $382M of net new capital in Q1 2026, opening 24 new positions. Its largest new stake was CRH: 2,654,974 shares worth $279M.
By sector, the portfolio is most concentrated in Materials at 81% of assets, followed by Technology and Communication Services.
- Eleva Capital's largest Q1 2026 buy was CRH: 2,654,974 shares worth $279M.
- Eleva Capital's ten largest holdings make up 98% of its $343M portfolio in Q1 2026.
- Eleva Capital opened 24 new positions and closed 0 in Q1 2026.
Based on Eleva Capital's 13F filing for Q1 2026, filed 15 Apr 2026.